Biodegradable Device Monitors Levels of Pesticides in Fruit, Vegetables

This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
TT

Biodegradable Device Monitors Levels of Pesticides in Fruit, Vegetables

This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)
This aerial photograph taken on Oct 31, 2022 shows a farmer spraying pesticide to a crop of cabbage cultivated in his field on the outskirts of Bengaluru. (AFP)

Researchers at the University of São Paulo (USP) and the Federal University of Viçosa (UFV) in Brazil have developed a sustainable sensor that can be placed directly on the surface of a vegetable or fruit to detect the presence of pesticides.

The device has the potential to help ensure food safety in a world that increasingly suffers from a shortage of food and the environmental and health problems caused by excessive use of agrochemicals. The results of the study were published in the journal Biomaterials Advances.

Pesticides are widely used to raise crop yields and are typically applied by spraying, but only 50% reach their target. The rest ends up in soil, groundwater, surface water, raw drinking water, wastewater and food products.

Monitoring of pesticide levels in water, soil and food is therefore essential to prevent contact between these toxic substances and the public via the skin, lungs or digestive system.

The researchers explained that the tools most often used for this purpose are chromatographic techniques (consist of separating and defining chemical compounds), which are effective but have drawbacks such as the need for pretreatment of samples, expensive equipment and qualified laboratory specialists, as well as the long time taken to complete the analysis. The unsafe residues produced by organic solvents are also a significant problem under present-day conditions.

As an alternative, electrochemical sensors can combine affordability, rapid detection, large-scale production, convenience, ease of use, high selectivity and in situ pesticide detection.

“Our invention has all these features. The analysis is performed directly on the surface of fruit, vegetables or leaves. It is made of cellulose acetate, a material derived from wood pulp,” said Paulo Augusto Raymundo-Pereira, co-author of the study.

“Instead of the usual materials, which are environmentally unsustainable and take a long time to degrade, such as ceramics or plastic polymers derived from petroleum, we used cellulose acetate, a material derived from plants that has little impact on the environment and disintegrates completely in 340 days or less depending on local conditions. It also has appropriate characteristics, including low cost, portability and flexibility,” he explained.

The researchers carried out laboratory tests in which a pesticide solution was sprayed on lettuce and tomatoes in a simulation of real-world use. The sensor was then directly attached to the lettuce and tomatoes, and measurements showed a level of detection compatible with those obtained with the sensor material most frequently used for this purpose.

The technology can be useful for sanitary surveillance agencies worldwide, farmers, as well as sellers of organic produce to certify absence of pesticides.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”